Suppliers / Kawman Pharma

Kawman Pharma

India Updated 9 July 2026

Kawman Pharma is an API manufacturer based in India. It holds 2 active US drug master files. Its GMP standing is certified by CDSCO (India).

2
active US DMFs
0
valid CEPs
2
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Cuddalore, India Not on file
cuddalore 607005, India Not on file

What they file, and where

Molecule Regulators Docs
Mupirocin US FDA 2

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) None 2

Questions about Kawman Pharma

Does Kawman Pharma hold a US DMF or a CEP?
Kawman Pharma holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Kawman Pharma manufacture?
2 registered sites are on record, in India (Cuddalore and Cuddalore 607005). Every site is listed on this page with the register it came from.
What does Kawman Pharma make?
1 molecule is on record against Kawman Pharma, including Mupirocin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Kawman Pharma's GMP?
Current GMP certificates are on record from CDSCO (India). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Kawman Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates